Black Men Report More Regret Over Prostate Cancer Treatment Decisions
Mistrust and concerns about masculinity are important factors that influence Black men’s experience during prostate cancer management.
Mistrust and concerns about masculinity are important factors that influence Black men’s experience during prostate cancer management.
Investigators evaluated a large sample of commercially insured patients with prostate cancer to assess use of tissue-based gene expression testing.
In a study of men on active surveillance for localized prostate cancer, each 1-unit increase in Mediterranean diet score, calculated based on patients’ baseline food frequency questionnaire information, was associated with a 12% decreased risk for Gleason grade group progression.
Orgovyx is an oral nonpeptide gonadotropin-releasing hormone (GnRH) receptor antagonist.
Investigators found no significant differences in 5-year RFS rates between RP and the other salvage modalities.
In a study, statin use was associated with a 36% decreased risk for death among men initiating androgen deprivation therapy for recurrent prostate cancer following primary or salvage radiation therapy.
Delaying radical prostatectomy for high-risk clinically localized prostate cancer for up to 6 months does not increase the risk for adverse pathologic outcomes, a study found.
Phase 3 trial data show 96.7 percent of patients who received Orgovyx achieved and maintained castrate levels of testosterone.
Patients with prostate cancer who received androgen deprivation therapy in the adjuvant setting instead of the neoadjuvant setting had better clinical outcomes.
Delayed radical prostatectomy not linked to higher risk for adverse pathological outcomes in high-risk prostate cancer.